Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sen. Chuck Grassley. Photo: Stefani Reynolds/Stringer

Sen. Chuck Grassley (R-Iowa) has tested positive for the coronavirus, adding Wednesday that he remains "symptom free."

Why it matters: Grassley is the second oldest member of the Senate at 87 years old, meaning he is at high risk for a severe infection, according to the CDC. The Iowa senator is the third in the line of succession to the presidency as president pro tempore of the Senate.

  • The Senator was seen at the Capitol speaking to reporters Monday afternoon, per CNN.
  • The announcement comes a week after Rep. Don Young (R-Alaska), who is also 87, announced he had contracted the virus.

What he's saying: Grassley wrote that he is "feeling good" and will continue to quarantine. He did not specify how he was exposed.

  • "I’ve tested positive for coronavirus. I’ll b following my doctors’ orders/CDC guidelines & continue to quarantine. I’m feeling good + will keep up on my work for the ppl of Iowa from home. I appreciate everyone’s well wishes + prayers &look fwd to resuming my normal schedule soon."

Worth noting: Grassley had not missed a Senate vote for 27 years until earlier Tuesday, when he wrote in a statement he would quarantine after being exposed to the virus. The Senate does not let members vote remotely.

Go deeper

Jan 29, 2021 - Health

WHO says most pregnant women can now receive coronavirus vaccine

A doctor administering Moderna's coronavirus vaccine at a university hospital in Essen, Germany, on Jan. 18. Photo: Lukas Schulze/Getty Images

The World Health Organization has altered its guidance for pregnant women who wish to receive the coronavirus vaccine, saying now that those at high risk of exposure to the COVID-19 or who have comorbidities that increase their risk of severe disease, may be vaccinated.

Why it matters: The WHO drew backlash for its previous guidance that did not recommend pregnant women be inoculated with vaccines made by Pfizer-BioNTech or Moderna, even though data indicated that pregnancy increased the risk of developing severe illness from the virus.

Updated Feb 23, 2021 - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: Axios-Ipsos poll: 1 in 3 Americans know someone who died from COVID-19 — Axios-Ipsos poll: Biden's window of opportunity on COVID — Nursing home COVID cases have drastically declinedU.S. death toll tops 500,000.
  2. Vaccine: Pfizer and Moderna expect to double vaccine shipments by spring — Fast-spreading misinformation on COVID vaccine and infertility worries health experts — Modified vaccines for variants would not require large clinical trials, FDA says.
  3. Economics: Small businesses say even second round of PPP loans not enoughU.S. growth expectations are going through the roof.
  4. Local: Denver breaks from Colorado's vaccine plan Twin Cities and some Midwest metros fare better economically than rest of U.S. — Federal vaccine distribution arriving in Tampa.
  5. World: Boris Johnson unveils roadmap to fully reopen England's economy by June.
Jan 29, 2021 - World

EU grants conditional approval of AstraZeneca vaccine

Photo: Sunil Ghosh/Hindustan Times via Getty Images

The European Commission on Friday granted conditional approval of the Oxford-AstraZeneca coronavirus vaccine for people 18 years and older.

Why it matters: This is the third vaccine to receive approval from the commission, coming hours after the Emergency Medicines Agency recommended its authorization.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!